BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1182 related articles for article (PubMed ID: 14522900)

  • 21. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
    Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
    Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GADD34 induces p53 phosphorylation and p21/WAF1 transcription.
    Yagi A; Hasegawa Y; Xiao H; Haneda M; Kojima E; Nishikimi A; Hasegawa T; Shimokata K; Isobe K
    J Cell Biochem; 2003 Dec; 90(6):1242-9. PubMed ID: 14635196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ING1a expression increases during replicative senescence and induces a senescent phenotype.
    Soliman MA; Berardi P; Pastyryeva S; Bonnefin P; Feng X; Colina A; Young D; Riabowol K
    Aging Cell; 2008 Dec; 7(6):783-94. PubMed ID: 18691180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
    Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.
    Ninomiya T; Mihara K; Fushimi K; Hayashi Y; Hashimoto-Tamaoki T; Tamaoki T
    Hepatology; 2002 Jan; 35(1):82-7. PubMed ID: 11786962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylases, HDAC1 and HSIR2, act as a negative regulator of ageing through p53 in human gingival fibroblast.
    Kim MM; Yoon SO; Cho YS; Chung AS
    Mech Ageing Dev; 2004 May; 125(5):351-7. PubMed ID: 15130752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
    Cheung KJ; Mitchell D; Lin P; Li G
    Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
    Liang SX; Richardson DR
    Carcinogenesis; 2003 Oct; 24(10):1601-14. PubMed ID: 12869419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
    Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
    Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
    Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
    Shiseki M; Nagashima M; Pedeux RM; Kitahama-Shiseki M; Miura K; Okamura S; Onogi H; Higashimoto Y; Appella E; Yokota J; Harris CC
    Cancer Res; 2003 May; 63(10):2373-8. PubMed ID: 12750254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Akashi M; Osawa Y; Koeffler HP; Hachiya M
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.